Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""recurrence"" wg kryterium: Temat


Tytuł :
Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer.
Autorzy :
Detsky JS; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Ghiam AF; University Health Network, Toronto, Ontario, Canada.
Mamedov A; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Commisso K; Department of Radiation Oncology, BC Cancer Agency, Victoria, British Columbia, Canada.; University Health Network, Toronto, Ontario, Canada.
Commisso A; Department of Radiation Oncology, BC Cancer Agency, Victoria, British Columbia, Canada.; University Health Network, Toronto, Ontario, Canada.
Zhang L; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Liu S; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Klotz L; Division of Urology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Loblaw A; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Vesprini D; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 934-940. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasm Recurrence, Local/*epidemiology
Patient Compliance/*statistics & numerical data
Prostate/*pathology
Prostatic Neoplasms/*therapy
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy/statistics & numerical data ; Disease Progression ; Disease-Free Survival ; Follow-Up Studies ; Humans ; Kallikreins/blood ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/prevention & control ; Prospective Studies ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/mortality ; Retrospective Studies ; Watchful Waiting/methods
Czasopismo naukowe
Tytuł :
Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy.
Autorzy :
Kanthabalan A; Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.
Arya M; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.
Freeman A; Department of Histopathology, UCLH NHS Foundation Trust, London, United Kingdom.
Mitra AV; Department of Clinical Oncology, UCLH NHS Foundation Trust, London, United Kingdom.
Payne H; Department of Clinical Oncology, UCLH NHS Foundation Trust, London, United Kingdom.
Peters M; Department of Radiation Oncology, University Medical Centre Utrecht, The Netherlands.
Shah TT; Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK.; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Imperial Urology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Emberton M; Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.
Ahmed HU; Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK.; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Imperial Urology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 950-955. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
Ablation Techniques/*methods
Kallikreins/*blood
Neoplasm Recurrence, Local/*therapy
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*therapy
Salvage Therapy/*methods
Ablation Techniques/adverse effects ; Aged ; Humans ; Image-Guided Biopsy/methods ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/pathology ; Patient Selection ; Positron Emission Tomography Computed Tomography ; Prostate/diagnostic imaging ; Prostate/pathology ; Prostate/radiation effects ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Risk Assessment ; Salvage Therapy/adverse effects
Czasopismo naukowe
Tytuł :
The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis.
Autorzy :
Miura N; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Ehime University Graduate School of Medicine, Ehime, Japan.
Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Mostafaei H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Motlagh RS; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Hospital of Tours, Tours, France.
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Saika T; Department of Urology, Ehime University Graduate School of Medicine, Ehime, Japan.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Department of Urology, Weill Cornell Medical College, New York, New York.; Department of Urology, University of Texas Southwestern, Dallas, Texas.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Urology, University of Jordan, Amman, Jordan.; European Association of Urology Research Foundation, Arnhem, The Netherlands.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 909-917. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Prostatectomy*
Carcinoma, Intraductal, Noninfiltrating/*mortality
Neoplasm Recurrence, Local/*epidemiology
Prostate/*pathology
Prostatic Neoplasms/*mortality
Biopsy ; Carcinoma, Intraductal, Noninfiltrating/blood ; Carcinoma, Intraductal, Noninfiltrating/diagnosis ; Carcinoma, Intraductal, Noninfiltrating/therapy ; Clinical Decision-Making ; Disease-Free Survival ; Humans ; Kallikreins/blood ; Male ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/prevention & control ; Prognosis ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer.
Autorzy :
Pak S; Department of Urology, Center for Urologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Suh YS; Department of Urology, Center for Urologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.; Seoul Urology Clinic, Seoul Urology Group, Seoul, Korea.
Lee DE; Biostatistics Collaboration Team, Research Core Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Kim SH; Department of Urology, Center for Urologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Joung JY; Department of Urology, Center for Urologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Park WS; Department of Pathology, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Lee SJ; Division of Cancer Immunology, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Lee KH; Department of Urology, Center for Urologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Jun; Vol. 203 (6), pp. 1128-1134. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplastic Cells, Circulating*
Prostatectomy*
Biomarkers, Tumor/*blood
Neoplasm Recurrence, Local/*diagnosis
Prostatic Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Postoperative Care ; Prospective Studies ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Editorial Comment.
Autorzy :
Chandrasekar T; Department of Urology, Sidney Kimmel Cancer Center Thomas Jefferson University, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Aug; Vol. 204 (2), pp. 301-302. Date of Electronic Publication: 2020 May 19.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Neoplasm Recurrence, Local*
Prostatic Neoplasms*
Carbon Radioisotopes ; Choline ; Humans ; Lymph Node Excision ; Male ; Membrane Glycoproteins ; Organometallic Compounds ; Positron-Emission Tomography ; Tumor Burden
Czasopismo naukowe
Tytuł :
Editorial Comment.
Autorzy :
Reese AC; Department of Urology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Aug; Vol. 204 (2), pp. 302. Date of Electronic Publication: 2020 May 19.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Neoplasm Recurrence, Local*
Prostatic Neoplasms*
Carbon Radioisotopes ; Choline ; Humans ; Lymph Node Excision ; Male ; Membrane Glycoproteins ; Organometallic Compounds ; Positron-Emission Tomography ; Tumor Burden
Czasopismo naukowe
Tytuł :
Re: 3-Year Freedom from Progression following GaPSMA PET CT Triaged Management in Men with Biochemical Recurrence Post Radical Prostatectomy. Results of a Prospective Multi-Center Trial.
Autorzy :
Taneja SS
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Jun; Vol. 203 (6), pp. 1063. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Neoplasm Recurrence, Local*
Positron Emission Tomography Computed Tomography*
Freedom ; Humans ; Male ; Membrane Glycoproteins ; Organometallic Compounds ; Prospective Studies ; Prostatectomy
Czasopismo naukowe
Tytuł :
Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.
Autorzy :
Mori K; Department of Urology, Medical University of Vienna, Vienna, Austria.; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
Janisch F; Department of Urology, Medical University of Vienna, Vienna, Austria.; Department of Urology, Medical University of Hamburg, Hamburg, Germany.
Parizi MK; Department of Urology, Medical University of Vienna, Vienna, Austria.; Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mostafaei H; Department of Urology, Medical University of Vienna, Vienna, Austria.; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Lysenko I; Department of Urology, Medical University of Vienna, Vienna, Austria.
Kimura S; Department of Urology, Medical University of Vienna, Vienna, Austria.; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
Enikeev DV; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Egawa S; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
Shariat SF; Department of Urology, Medical University of Vienna, Vienna, Austria.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, Weill Cornell Medical College, New York, New York.; Department of Urology, University of Texas Southwestern, Dallas, Texas.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic, Russia.; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Jun; Vol. 203 (6), pp. 1075-1084. Date of Electronic Publication: 2019 Sep 03.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Carcinoma, Transitional Cell/*surgery
Kidney Neoplasms/*surgery
Neoplasm Recurrence, Local/*diagnosis
Ureteral Neoplasms/*surgery
Urothelium/*pathology
Carcinoma, Transitional Cell/mortality ; Carcinoma, Transitional Cell/pathology ; Clinical Decision-Making/methods ; Disease-Free Survival ; Feasibility Studies ; Humans ; Kaplan-Meier Estimate ; Kidney/pathology ; Kidney/surgery ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Neoplasm Recurrence, Local/prevention & control ; Nephroureterectomy ; Patient Selection ; Predictive Value of Tests ; Prognosis ; Ureter/pathology ; Ureter/surgery ; Ureteral Neoplasms/mortality ; Ureteral Neoplasms/pathology ; Urothelium/surgery
Czasopismo naukowe
Tytuł :
Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.
Autorzy :
Lee Z; Fox Chase Cancer Center-Temple Health System, Philadelphia, Pennsylvania.
Jegede OA; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
Haas NB; University of Pennsylvania, Philadelphia, Pennsylvania.
Pins MR; Advocate Lutheran General Hospital, Park Ridge, Illinois.
Messing EM; University of Rochester, Rochester, New York.
Manola J; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
Wood CG; MD Anderson Cancer Center, Houston, Texas.
Kane CJ; University of California-San Diego, La Jolla, California.
Jewett MAS; University of Toronto, Toronto, Ontario, Canada.
Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Dutcher JP; Cancer Research Foundation of New York, Chappaqua, New York.
DiPaola RS; University of Kentucky College of Medicine, Lexington, Kentucky.
Uzzo RG; Fox Chase Cancer Center-Temple Health System, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Apr; Vol. 203 (4), pp. 684-689. Date of Electronic Publication: 2019 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Nephrectomy*
Carcinoma, Renal Cell/*therapy
Kidney/*pathology
Kidney Neoplasms/*mortality
Kidney Neoplasms/*therapy
Neoplasm Recurrence, Local/*epidemiology
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Carcinoma, Renal Cell/diagnostic imaging ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Chemotherapy, Adjuvant/methods ; Clinical Trials, Phase III as Topic ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Kidney/diagnostic imaging ; Kidney/surgery ; Kidney Neoplasms/diagnostic imaging ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Multicenter Studies as Topic ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Prospective Studies ; Randomized Controlled Trials as Topic ; Risk Assessment ; Sorafenib/therapeutic use ; Sunitinib/therapeutic use
Czasopismo naukowe
Tytuł :
Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy.
Autorzy :
Pouliot F; Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Ontario, Canada.
Rouleau M; Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Ontario, Canada.
Neveu B; Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Ontario, Canada.
Toren P; Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Ontario, Canada.
Morin F; Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Ontario, Canada.
Vélot L; Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Ontario, Canada.
Ding K; NCIC Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.
Caron P; Pharmacy Faculty, Université Laval and CHU de Québec-Université Laval, Québec, Ontario, Canada.
Lacombe L; Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Ontario, Canada.
Lévesque É; Medicine Faculty, Université Laval and CHU de Québec-Université Laval, Québec, Ontario, Canada.
Klotz L; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Guillemette C; Pharmacy Faculty, Université Laval and CHU de Québec-Université Laval, Québec, Ontario, Canada.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 May; Vol. 203 (5), pp. 940-948. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Androstenedione/*pharmacology
Castration/*methods
Neoplasm Recurrence, Local/*therapy
Prostatic Neoplasms/*therapy
Receptors, Androgen/*metabolism
Testosterone/*analogs & derivatives
Testosterone/*pharmacology
Anabolic Agents/pharmacology ; Androgens/pharmacology ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; Follow-Up Studies ; Humans ; Male ; Mass Spectrometry ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Prospective Studies ; Prostate/drug effects ; Prostate/metabolism ; Prostate/pathology ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Receptors, Androgen/drug effects ; Time Factors
Czasopismo naukowe
Tytuł :
Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound.
Autorzy :
Huber PM; Department of Urology, University Hospital Inselspital Berne, Bern, Switzerland.; Department of Urology, Bern and St. Anna Klinik Lucerne, Lucerne, Switzerland.; Department of Urology, University College London Hospital, NHS Foundation Trust, London, United Kingdom.; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Afzal N; Department of Urology, Dorset County Hospital NHS Trust, Dorset, United Kingdom.
Arya M; Department of Urology, University College London Hospital, NHS Foundation Trust, London, United Kingdom.; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom.
Boxler S; Department of Urology, University Hospital Inselspital Berne, Bern, Switzerland.
Dudderidge T; Department of Urology, University Hospital Southampton NHS Trust, Southampton, United Kingdom.
Emberton M; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; Department of Urology, University College London Hospital, NHS Foundation Trust, London, United Kingdom.
Guillaumier S; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; Department of Urology, University College London Hospital, NHS Foundation Trust, London, United Kingdom.
Hindley RG; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, United Kingdom.
Hosking-Jervis F; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Leemann L; Department of Political Science, University of Zurich, Zürich, Switzerland.
Lewi H; Springfield Hospital, Chelmsford, United Kingdom.
McCartan N; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; Department of Urology, University College London Hospital, NHS Foundation Trust, London, United Kingdom.
Moore CM; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; Department of Urology, University College London Hospital, NHS Foundation Trust, London, United Kingdom.
Nigam R; Department of Urology, Royal County Surrey Hospital NHS Trust, Guildford, United Kingdom.
Odgen C; Department of Academic Urology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
Persad R; Department of Urology, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom.
Thalmann GN; Department of Urology, University Hospital Inselspital Berne, Bern, Switzerland.
Virdi J; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom.
Winkler M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Ahmed HU; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Apr; Vol. 203 (4), pp. 734-742. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji :
Journal Article
MeSH Terms :
Ultrasound, High-Intensity Focused, Transrectal*
Androgen Antagonists/*therapeutic use
Kallikreins/*blood
Neoplasm Recurrence, Local/*diagnosis
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*therapy
Aged ; Feasibility Studies ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoadjuvant Therapy/methods ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/prevention & control ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate/pathology ; Prostate/radiation effects ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Sensitivity and Specificity ; Treatment Failure
Czasopismo naukowe
Tytuł :
Re: Ga-PSMA-11 PET-CT in Patients with Early Biochemical Recurrence after Prostatectomy: A Prospective, Single-Centre, Single-Arm, Comparative Imaging Trial.
Autorzy :
Taneja SS
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Apr; Vol. 203 (4), pp. 661-662. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Neoplasm Recurrence, Local*
Positron Emission Tomography Computed Tomography*
Humans ; Male ; Membrane Glycoproteins ; Organometallic Compounds ; Prospective Studies ; Prostatectomy
Czasopismo naukowe
Tytuł :
Late Recurrences Following Radical Cystectomy Have Distinct Prognostic and Management Considerations.
Autorzy :
Dason S; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Cha EK; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Falavolti C; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Vertosick EA; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center New York, New York.
Dean LW; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
McPherson VA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Sjoberg DD; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center New York, New York.
Benfante NE; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Donahue TF; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Dalbagni G; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Bochner BH; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, The Ohio State University, Columbus, Ohio.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Sep; Vol. 204 (3), pp. 460-465. Date of Electronic Publication: 2020 Apr 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Carcinoma, Transitional Cell/*surgery
Cystectomy/*methods
Urinary Bladder Neoplasms/*surgery
Aged ; Carcinoma, Transitional Cell/mortality ; Carcinoma, Transitional Cell/pathology ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Risk Factors ; Survival Rate ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer.
Autorzy :
Markowski MC; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Sedhom R; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Fu W; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Gray JCR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Eisenberger MA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Pomper MG; The Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Pienta KJ; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Gorin MA; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Rowe SP; The Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Sep; Vol. 204 (3), pp. 496-502. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*diagnostic imaging
Aged ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
Autorzy :
Gontero P; Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy.
Marra G; Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy.
Alessio P; Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy.
Filippini C; Department of Statistics, University of Turin, Turin, Italy.
Oderda M; Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy.
Munoz F; Department of Radiotherapy, Parini Hospital, Aosta, Italy.
Linares E; Department of Urology, Institut Mutualiste Montsouris, F-75013 Paris, France.
Sanchez-Salas R; Department of Urology, Institut Mutualiste Montsouris, F-75013 Paris, France.
Challacombe B; Urology 47 Centre, Guy's Hospital, London, United Kingdom.
Dasgupta P; Urology 47 Centre, Guy's Hospital, London, United Kingdom.; King's College London, London, United Kingdom.
Goonewardene S; Urology 47 Centre, Guy's Hospital, London, United Kingdom.
Popert R; Urology 47 Centre, Guy's Hospital, London, United Kingdom.
Cahill D; Royal Marsden Hospital, London, United Kingdom.
Gillatt D; Bristol NHS Foundation Trust, Bristol, United Kingdom.
Persad R; Bristol NHS Foundation Trust, Bristol, United Kingdom.
Palou J; Fundaciò Puigvert, Barcelona, Spain.
Joniau S; Leuven University Hospitals, Leuven, Belgium.
Piechaud T; Clinique Saint Augustin, Bordeaux, France.
Morlacco A; Mayo Clinic, Rochester, Minnesota.
Vidit S; Mayo Clinic, Rochester, Minnesota.
Rouprêt M; Sorbonne Université, GRC No. 5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, F-75013 Paris, France.
De La Taille A; CHU Mondor, Créteil, France.
Albisinni S; Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
Gandaglia G; OLV Hospital, Aalst, Belgium.
Mottrie A; OLV Hospital, Aalst, Belgium.
Joshi S; Vanderbilt University, Medical Center North, Nashville, Tennessee.
Fiscus G; Vanderbilt University, Medical Center North, Nashville, Tennessee.
Berger A; USC Norris Comprehensive Cancer Center and Hospital, University of Southern California, California.
Aron M; USC Norris Comprehensive Cancer Center and Hospital, University of Southern California, California.
Van Der Poel H; Netherlands Cancer Institute, Amsterdam, Netherlands.
Tilki D; Martini-Klinik Prostate Cancer Center and Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne and Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne and Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Leung G; Division of Surgery, Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Davis J; Division of Surgery, Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Karnes RJ; Department of Oncology, University of Turin, Turin, Italy.
Pokaż więcej
Corporate Authors :
Collaborators
Źródło :
The Journal of urology [J Urol] 2019 Oct; Vol. 202 (4), pp. 725-731. Date of Electronic Publication: 2019 Sep 06.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Neoplasm Recurrence, Local/*surgery
Prostatectomy/*adverse effects
Prostatic Neoplasms/*surgery
Robotic Surgical Procedures/*adverse effects
Salvage Therapy/*adverse effects
Aged ; Blood Loss, Surgical/statistics & numerical data ; Constriction, Pathologic/epidemiology ; Constriction, Pathologic/etiology ; Follow-Up Studies ; Humans ; Incidence ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Prostate/pathology ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatectomy/methods ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Robotic Surgical Procedures/methods ; Salvage Therapy/methods ; Treatment Outcome ; Urinary Incontinence/epidemiology ; Urinary Incontinence/etiology
Czasopismo naukowe
Tytuł :
Augmented Anastomotic Urethroplasty is Independently Associated with Failure after Reconstruction for Long Bulbar Urethral Strictures.
Autorzy :
Redmond EJ; Division of Urology, University of Alberta, Edmonton, Alberta, Canada.
Hoare DT; Division of Urology, University of Alberta, Edmonton, Alberta, Canada.
Rourke KF; Division of Urology, University of Alberta, Edmonton, Alberta, Canada.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 989-995. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Mouth Mucosa/*transplantation
Reconstructive Surgical Procedures/*adverse effects
Surgical Flaps/*adverse effects
Urethral Stricture/*surgery
Urologic Surgical Procedures, Male/*adverse effects
Adult ; Anastomosis, Surgical/adverse effects ; Anastomosis, Surgical/methods ; Humans ; Male ; Middle Aged ; Reconstructive Surgical Procedures/methods ; Recurrence ; Retrospective Studies ; Surgical Flaps/transplantation ; Treatment Failure ; Treatment Outcome ; Urethra/pathology ; Urethra/surgery ; Urologic Surgical Procedures, Male/methods
Czasopismo naukowe
Tytuł :
A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance.
Autorzy :
Kornberg Z; Department of Urology, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Cooperberg MR; Department of Urology, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California.
Cowan JE; Department of Urology, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Chan JM; Department of Urology, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California.
Shinohara K; Department of Urology, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Simko JP; Department of Pathology, University of California-San Francisco, San Francisco, California.
Tenggara I; Department of Urology, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Carroll PR; Department of Urology, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2019 Oct; Vol. 202 (4), pp. 702-709. Date of Electronic Publication: 2019 Sep 06.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Biomarkers, Tumor/*genetics
Genetic Testing/*methods
Neoplasm Recurrence, Local/*diagnosis
Prostatic Neoplasms/*diagnosis
Watchful Waiting/*methods
Aged ; Biopsy ; Disease Progression ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Predictive Value of Tests ; Prognosis ; Prostate/pathology ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/surgery ; Retrospective Studies ; Risk Assessment/methods ; Time-to-Treatment
Czasopismo naukowe
Tytuł :
American Urological Association Nonmuscle Invasive Bladder Cancer Risk Model Validation-Should Patient Age be Added to the Risk Model?
Autorzy :
Ravvaz K; Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin.
Weissert JA; Aurora Research Institute, Aurora Health Care, Milwaukee, Wisconsin.
Downs TM; Department of Urology, School of Medicine and Public Health and Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, Wisconsin.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2019 Oct; Vol. 202 (4), pp. 682-688. Date of Electronic Publication: 2019 Sep 06.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Neoplasm Recurrence, Local/*diagnosis
Urinary Bladder Neoplasms/*mortality
Age Factors ; Aged ; Aged, 80 and over ; Disease Progression ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Progression-Free Survival ; Registries/statistics & numerical data ; Retrospective Studies ; Risk Assessment/methods ; Risk Factors ; United States/epidemiology ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance.
Autorzy :
Balakrishnan AS; Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Cowan JE; Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Cooperberg MR; Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Shinohara K; Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Nguyen HG; Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Carroll PR; Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2019 Sep; Vol. 202 (3), pp. 506-510. Date of Electronic Publication: 2019 Aug 08.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local/*epidemiology
Outcome Assessment, Health Care/*statistics & numerical data
Prostatectomy/*statistics & numerical data
Prostatic Neoplasms/*diagnosis
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy, Large-Core Needle ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/blood ; Patient Selection ; Prostate/pathology ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatectomy/methods ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/epidemiology ; Prostatic Neoplasms/therapy ; Risk Assessment ; Time Factors ; Time-to-Treatment/statistics & numerical data
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies